These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 24858397)

  • 21. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma.
    Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L
    Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Co-delivery of doxorubicin and Bmi1 siRNA by folate receptor targeted liposomes exhibits enhanced anti-tumor effects in vitro and in vivo.
    Yang T; Li B; Qi S; Liu Y; Gai Y; Ye P; Yang G; Zhang W; Zhang P; He X; Li W; Zhang Z; Xiang G; Xu C
    Theranostics; 2014; 4(11):1096-111. PubMed ID: 25285163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model.
    Pan XQ; Wang H; Lee RJ
    Pharm Res; 2003 Mar; 20(3):417-22. PubMed ID: 12669962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface-Modified Nanoerythrocyte Loading DOX for Targeted Liver Cancer Chemotherapy.
    Wang Y; Chen X; He D; Zhou Y; Qin L
    Mol Pharm; 2018 Dec; 15(12):5728-5740. PubMed ID: 30359027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional LAPONITE Nanodisks Enable Targeted Anticancer Chemotherapy
    Wu Y; Li K; Kong L; Tang Y; Li G; Jiang W; Shen M; Guo R; Zhao Q; Shi X
    Bioconjug Chem; 2020 Oct; 31(10):2404-2412. PubMed ID: 33001643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
    Zhang C; Wu Y; Dong Y; Xu H; Zhao L
    Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation.
    Cheng L; Huang FZ; Cheng LF; Zhu YQ; Hu Q; Li L; Wei L; Chen DW
    Int J Nanomedicine; 2014; 9():921-35. PubMed ID: 24611009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo evaluation of folate receptor-targeting amphiphilic copolymer-modified liposomes loaded with docetaxel.
    Li X; Tian X; Zhang J; Zhao X; Chen X; Jiang Y; Wang D; Pan W
    Int J Nanomedicine; 2011; 6():1167-84. PubMed ID: 21852896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folate receptor targeted biodegradable polymeric doxorubicin micelles.
    Yoo HS; Park TG
    J Control Release; 2004 Apr; 96(2):273-83. PubMed ID: 15081218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
    Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N
    J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
    Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ
    Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
    Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
    Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pH-Sensitive PEGylated Liposomal Silybin: Synthesis, In Vitro and In Vivo Anti-Tumor Evaluation.
    Gheybi F; Alavizadeh SH; Rezayat SM; Hatamipour M; Akhtari J; Faridi Majidi R; Badiee A; Jaafari MR
    J Pharm Sci; 2021 Dec; 110(12):3919-3928. PubMed ID: 34418455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate.
    Yoo HS; Park TG
    J Control Release; 2004 Nov; 100(2):247-56. PubMed ID: 15544872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity.
    Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A
    J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.